Anders D. Hove, 10% Owner at Avalanche Biotechnologies, Inc. (AAVL), bought 2,365,471 shares at $17.00 ($6.8M) on 2014-08-05, disclosed to the SEC on 2014-08-07.
Open-market purchase of $6.8M AAVL by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,965,471 | $0 | 0.0% |
| 2 | $17.00 | 400,000 | $6.8M | 100.0% |
| Total | $2.87 avg | 2,365,471 | $6.8M | 100% |
| Filing → |
| ANAC | SELL | 2015-12-17 | $100.1M | — | Filing → |
| ANAC | SELL | 2015-12-15 | $4.7M | — | Filing → |
| ANAC | SELL | 2015-11-12 | $10.4M | — | Filing → |